• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Immunology

Mysteries of malaria infections deepen after human trial study

Bioengineer by Bioengineer
March 30, 2021
in Immunology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Scientists have discovered that tracking malaria as it develops in humans is a powerful way to detect how the malaria parasite causes a range of infection outcomes in its host

IMAGE

Credit: Professor Alex Rowe, Personal Chair of Molecular Medicine, Institute of Infection and Immunology Research, University of Edinburgh

Scientists have discovered that tracking malaria as it develops in humans is a powerful way to detect how the malaria parasite causes a range of infection outcomes in its host.

The study, found some remarkable differences in the way individuals respond to malaria and raises fresh questions in the quest to understand and defeat the deadly disease.

Malaria, caused by the parasite – Plasmodium falciparum – is a huge threat to adults and children in the developing world. Each year, around half a million people die from the disease and another 250 million are infected. Malaria parasites are spread to humans through the bites of infected mosquitoes.

The outcomes that follow a malaria infection can vary from no symptoms to life-threatening disease and death. The precise reasons why people respond in different ways to the same parasite infection are still unknown, experts say.

Researchers from the University of Edinburgh, in collaboration with teams at the Universities of Oxford and Glasgow and the Wellcome Trust Sanger Institute, explored infection outcomes in 14 volunteers who were injected with malaria parasites.

Scientists studied how the volunteers responded to the parasites over the course of 10 days. The group were then treated with antimalarial drugs to cure the infection before there was any risk of them developing severe symptoms.

The study, published in eLife, found that the immune systems in about half of the volunteers were rapidly alerted to the presence of parasites and began to produce signals to mobilise host defences.

These volunteers began to suffer symptoms of malaria such as fever and headache. The other volunteers, however, either showed no sign of immune activation, or else started to develop responses to dampen their body’s immune response. These volunteers did not develop malaria symptoms.

Dr Phil Spence, Sir Henry Dale Fellow, Institute of Infection and Immunology Research, University of Edinburgh and one of the project leads, said: “It looks like most of the variation in malaria is due to intrinsic differences between people in how they respond to infection.

“We need to do further work to tease out the underlying factors responsible for immune variation, such as investigating human genetics and prior experience of other infections.”

The study also asked whether variation in parasite growth rate, the rate at which a parasite replicates within the body, or virulence factors, the properties of a parasite thought to make an infection more severe, were different in the volunteers and if this had a bearing on infection outcomes.

Surprisingly, the researchers found that although parasite growth rates did vary substantially between volunteers, this was not linked to outcomes. For example, a volunteer could have a small number of parasites with a strong immune reaction or have a large number with no symptoms.

Furthermore, monitoring the parasite virulence factors through time, in particular a family of molecules called group A var genes, showed no differences between volunteers and no changes over the course of infection.

Professor Alex Rowe, Personal Chair of Molecular Medicine, Institute of Infection and Immunology Research, University of Edinburgh and project co-lead, said: “The biggest surprise from our study was that there was no variation in expression of the parasite virulence factors.

“Current theory, based on data from infected patients in malarious countries, suggested that parasites expressing group A var genes would rapidly come to dominate as the infection progressed, but this was not seen in our volunteers.

“There are many possible reasons for this – maybe a parasite collected more recently from a field site would give a different result, or maybe longer infection times are needed so the host immune response can influence these changes.”

The unexpected results from this study shows the power of human volunteer studies to raise new questions and give novel insights into diseases that have been studied in other ways for many decades, according to the team.

###

The study was funded by the Wellcome Trust and the UK Medical Research Council.

For further information, please contact: Rhona Crawford, Press and PR Office, 0131 650 2246, [email protected]

Media Contact
Rhona Crawford
[email protected]

Related Journal Article

http://dx.doi.org/10.7554/eLife.62800

Tags: Cell BiologyClinical TrialsInfectious/Emerging DiseasesMedicine/HealthParasitology
Share12Tweet8Share2ShareShareShare2

Related Posts

IMAGE

UMass Amherst grad student awarded fellowship for food allergy research

July 23, 2021
IMAGE

Less-sensitive COVID-19 tests may still achieve optimal results if enough people tested

July 22, 2021

Public trust in CDC, FDA, and Fauci holds steady, survey shows

July 20, 2021

USC study shows male-female differences in immune cell function

July 19, 2021
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    38 shares
    Share 15 Tweet 10
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    36 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Gut γδ T17 Cells Drive Brain Inflammation via STING

Agent-Based Framework for Assessing Environmental Exposures

MARCO Drives Myeloid Suppressor Cell Differentiation, Immunity

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.